In April 2010, Alexander Kel and myself have founded geneXplain GmbH, for which I'm taking on the CEO position. The task of this new company is to develop and provide a bioinformatics and systems-biological platform for personalized pharmacogenomics research. It will also offer its specific expertise to research partnerships and for corresponding services.
More information about the company and its products has been published on LinkedIn and Facebook. In particular, we have deposited three picture galleries on Facebook about the most important products geneXplain is presently distributing: